Publications by authors named "Tomoyuki Imagawa"

Are you Tomoyuki Imagawa?   Register this Author


Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis.
Rheumatology (Oxford) 2015 May 6;54(5):784-91. Epub 2014 Oct 6.
Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Department of Immunology and Infectious Diseases, Aichi Children's Health and Medical Center, Ohbu, Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama, Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Department of Pediatrics, Ehime University Graduate School of Medicine, Matsuyama, Department of Allergy & Immunology, Hyogo Prefectural Kobe Children's Hospital, Kobe, Department of Pediatrics, University of the Ryukyus, Naha, Department of Pediatrics, Osaka Medical College, Takatsuki, Department of Pediatrics, Kurume University School of Medicine, Kurume, Department of General Pediatrics, Miyagi Children's Hospital, Sendai, Division of Infection, Immunology and Rheumatology, Kanagawa Children's Medical Center, Yokohama, Department of Infection and Host Defense, Shinshu University Graduate School of Medicine, Matsumoto, Department of Rheumatology, Tokai University School of Medicine, Isehara, Department of Rheumatology, Keio University School of Medicine, Tokyo and School of Health Science, Faculty of Medicine, Kagoshima University, Kagoshima, Japan.

Discrepancy between clinical and radiological responses to tocilizumab treatment in patients with systemic-onset juvenile idiopathic arthritis.
J Rheumatol 2014 Jun 1;41(6):1171-7. Epub 2014 May 1.
From the Department of Orthopedic Surgery, the Department of Pediatrics, and the Department of Biostatistics and Epidemiology, Yokohama City University, Yokohama, Japan.C. Aoki, MD; Y. Inaba, MD, PhD, Associate Professor; H. Choe, MD, PhD, Department of Orthopedic Surgery; U. Kaneko, MD; R. Hara, MD, PhD; T. Miyamae, MD, PhD; T. Imagawa, MD, PhD; M. Mori, MD, PhD, Associate Professor, Department of Pediatrics; M.S. Oba, Department of Biostatistics and Epidemiology; S. Yokota, MD, Professor of Pediatrics, Department of Pediatrics; T. Saito, MD, Professor of Orthopedics, Department of Orthopedic Surgery, Yokohama City University.


Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan.
J Rheumatol 2014 Apr 15;41(4):759-67. Epub 2014 Mar 15.
From the Department of Pediatrics, Yokohama City University School of Medicine, and Department of Pediatrics, Yokohama City University Medical Center; Yokohama; School of Health Science, Faculty of Medicine, Kagoshima University, Kagoshima; Aichi Children's Health and Medical Center, Aichi; Miyagi Children's Hospital, Miyagi; Department of Pediatrics, Osaka Medical College, Osaka; Kobe Children's Hospital, Kobe; Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba; Department of Molecular Regulation for Intractable Diseases, Institute of Medical Science, Tokyo Medical University, Osaka; Immunology Frontier Research Center, Osaka University, Osaka, Japan.

Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndrome in Japan.
Mod Rheumatol 2013 May 20;23(3):425-9. Epub 2012 Oct 20.
Department of Pediatrics, Yokohama City University School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.


A pediatric patient with myopathy associated with antibodies to a signal recognition particle.
Brain Dev 2012 Nov 19;34(10):877-80. Epub 2012 Mar 19.
Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.


Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis.
Mod Rheumatol 2012 Aug 9;22(4):558-64. Epub 2011 Oct 9.
Department of Pediatrics, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series.
J Rheumatol 2012 Apr 15;39(4):864-7. Epub 2012 Feb 15.
Department of Pediatrics, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan.

Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis.
Mod Rheumatol 2012 Feb 12;22(1):109-15. Epub 2011 Jun 12.
Department of Pediatrics, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236-0004, Japan.




Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis.
J Rheumatol 2011 Apr 15;38(4):769-74. Epub 2011 Jan 15.
Department of Pediatrics, Yokohama City University Graduate School of Medicine; and the CNV Laboratory, DNA Chip Research Institute, Yokohama, Japan.





Intravenous methylprednisolone pulse therapy for children with autoimmune hepatitis.
Hepatol Res 2006 Mar 31;34(3):187-92. Epub 2006 Jan 31.
Department of Pediatrics, Atami Hospital, International University of Health and Welfare, 13-1, Higashikaigancho, Atami City, Shizuoka 413-0012, Japan; Department of Pathology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.


Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy.
Arthritis Res Ther 2005 4;7(4):R746-55. Epub 2005 Apr 4.
Division of Rheumatology, Children's Hospital of Pittsburgh, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.





OF